{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T12:43:38Z","timestamp":1722689018881},"reference-count":53,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1210\/en.2018-00109","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T18:08:10Z","timestamp":1528222090000},"page":"2741-2758","source":"Crossref","is-referenced-by-count":16,"title":["Eldecalcitol Causes FGF23 Resistance for Pi Reabsorption and Improves Rachitic Bone Phenotypes in the Male Hyp Mouse"],"prefix":"10.1210","volume":"159","author":[{"given":"Ichiro","family":"Kaneko","sequence":"first","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Segawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo","family":"Ikuta","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Hanazaki","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Kido","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Amizuka","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Chugai Pharmaceutical Co., Ltd., Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Nutrition, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"9","key":"2019041122104117700_B1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr J"},{"issue":"7","key":"2019041122104117700_B2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"27","key":"2019041122104117700_B3","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","article-title":"Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes","volume":"102","author":"Sabbagh","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041122104117700_B4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","volume":"11","author":"The HYP Consortium","year":"1995","journal-title":"Nat Genet"},{"issue":"12","key":"2019041122104117700_B5","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1073\/pnas.73.12.4667","article-title":"Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets","volume":"73","author":"Eicher","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019041122104117700_B6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00774-015-0698-7","article-title":"Pathogenesis and diagnostic criteria for rickets and osteomalacia\u2014proposal by an expert panel supported by the Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research, and the Japan Endocrine Society","volume":"33","author":"Fukumoto","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2019041122104117700_B7","doi-asserted-by":"crossref","first-page":"F1271","DOI":"10.1152\/ajprenal.00252.2003","article-title":"Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c","volume":"285","author":"Tenenhouse","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2019041122104117700_B8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00860736","article-title":"Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease","volume":"9","author":"Taylor","year":"1995","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2019041122104117700_B9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041122104117700_B10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbmr.1810","article-title":"Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets","volume":"28","author":"W\u00f6hrle","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041122104117700_B11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/en.2009-0564","article-title":"Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho\/HYP mouse","volume":"151","author":"Brownstein","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"2019041122104117700_B12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2007-1205","article-title":"Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP","volume":"149","author":"Martin","year":"2008","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122104117700_B13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.1766","article-title":"Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia","volume":"28","author":"Barros","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2019041122104117700_B14","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/en.2010-0354","article-title":"The receptor-dependent actions of 1,25-dihydroxyvitamin D are required for normal growth plate maturation in NPt2a knockout mice","volume":"151","author":"Miedlich","year":"2010","journal-title":"Endocrinology"},{"issue":"5","key":"2019041122104117700_B15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2783","article-title":"1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture, and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041122104117700_B16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/endo-111-3-904","article-title":"Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse","volume":"111","author":"Marie","year":"1982","journal-title":"Endocrinology"},{"issue":"4","key":"2019041122104117700_B17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"2019041122104117700_B18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00424-010-0888-z","article-title":"Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+-dependent phosphate cotransporters","volume":"461","author":"Kaneko","year":"2011","journal-title":"Pflugers Arch"},{"issue":"6","key":"2019041122104117700_B19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1248\/cpb.41.1111","article-title":"Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position","volume":"41","author":"Miyamoto","year":"1993","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2019041122104117700_B20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jsbmb.2015.01.016","article-title":"Eldecalcitol reduces osteoporotic fractures by unique mechanisms","volume":"148","author":"Kondo","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2019041122104117700_B21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-014-9937-5","article-title":"Long-term treatment with eldecalcitol (1\u03b1, 25-dihydroxy-2\u03b2- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats","volume":"96","author":"Takeda","year":"2015","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2019041122104117700_B22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jbmr.555","article-title":"Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone","volume":"27","author":"Harada","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019041122104117700_B23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bone.2011.05.022","article-title":"Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized rats","volume":"49","author":"de Freitas","year":"2011","journal-title":"Bone"},{"issue":"5","key":"2019041122104117700_B24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00223-011-9528-7","article-title":"The vitamin D analog 1\u03b1,25-dihydroxy-2\u03b2-(3-hydroxypropyloxy) vitamin D(3) (eldecalcitol) is a potent regulator of calcium and phosphate metabolism","volume":"89","author":"Brown","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"2019041122104117700_B25","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1210\/en.2012-1587","article-title":"The vitamin D analog ED-71 is a potent regulator of intestinal phosphate absorption and NaPi-IIb","volume":"153","author":"Brown","year":"2012","journal-title":"Endocrinology"},{"issue":"3-5","key":"2019041122104117700_B26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsbmb.2006.12.025","article-title":"Synthesis and biological evaluation of a 3-position epimer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy) vitamin D3 (ED-71)","volume":"103","author":"Hatakeyama","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1-2","key":"2019041122104117700_B27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jsbmb.2010.04.001","article-title":"Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo","volume":"121","author":"Harada","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2019041122104117700_B28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bone.2011.11.018","article-title":"Molecular characterisation of the Hyp deletion and an improved assay for its detection","volume":"50","author":"Sheen","year":"2012","journal-title":"Bone"},{"issue":"22","key":"2019041122104117700_B29","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1074\/jbc.M200943200","article-title":"Growth-related renal type II Na\/Pi cotransporter","volume":"277","author":"Segawa","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"2019041122104117700_B30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/oxfordjournals.jbchem.a022505","article-title":"A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase","volume":"126","author":"Oda","year":"1999","journal-title":"J Biochem"},{"issue":"7","key":"2019041122104117700_B31","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1210\/en.2015-2028","article-title":"Frequency of teriparatide administration affects the histological pattern of bone formation in young adult male mice","volume":"157","author":"Yamamoto","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122104117700_B32","doi-asserted-by":"crossref","first-page":"G496","DOI":"10.1152\/ajpgi.00167.2004","article-title":"Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine","volume":"288","author":"Radanovic","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"2019041122104117700_B33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/BF01213366","article-title":"Sodium-phosphate transport in the kidney and intestine of the hypophosphatemic mouse","volume":"7","author":"Nakagawa","year":"1993","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2019041122104117700_B34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/endo-111-2-650","article-title":"Secondary hyperparathyroidism in X-linked hypophosphatemic mice","volume":"111","author":"Kiebzak","year":"1982","journal-title":"Endocrinology"},{"issue":"10","key":"2019041122104117700_B35","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/en.2007-0243","article-title":"Early lethality in Hyp mice with targeted deletion of PTH gene","volume":"148","author":"Bai","year":"2007","journal-title":"Endocrinology"},{"key":"2019041122104117700_B36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsbmb.2013.11.013","article-title":"Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo","volume":"144","author":"Saito","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Pt 2","key":"2019041122104117700_B37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/000456329803500203","article-title":"Renal tubular reabsorption of phosphate (TmP\/GFR): indications and interpretation","volume":"35","author":"Payne","year":"1998","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"2019041122104117700_B38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2019041122104117700_B39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF02411227","article-title":"Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse","volume":"34","author":"Marie","year":"1982","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"2019041122104117700_B40","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/jbmr.3197","article-title":"Therapeutic effects of FGF23 c-tail Fc in a murine preclinical model of X-linked hypophosphatemia via the selective modulation of phosphate reabsorption","volume":"32","author":"Johnson","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041122104117700_B41","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/en.2011-1831","article-title":"Chronic inhibition of ERK1\/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice","volume":"153","author":"Zhang","year":"2012","journal-title":"Endocrinology"},{"issue":"6","key":"2019041122104117700_B42","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.2741\/e526","article-title":"Histology of epiphyseal cartilage calcification and endochondral ossification","volume":"4","author":"Amizuka","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"issue":"1","key":"2019041122104117700_B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1349-0079(08)80014-X","article-title":"Current concepts of bone biomineralization","volume":"50","author":"Ozawa","year":"2008","journal-title":"J Oral Biosci"},{"issue":"3","key":"2019041122104117700_B44","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/endo-110-3-1030","article-title":"X-linked hypophosphatemic mice are not hypersensitive to parathyroid hormone","volume":"110","author":"Kiebzak","year":"1982","journal-title":"Endocrinology"},{"issue":"1","key":"2019041122104117700_B45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019041122104117700_B46","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2019041122104117700_B47","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","article-title":"Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4","volume":"301","author":"Gattineni","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2019041122104117700_B48","doi-asserted-by":"crossref","first-page":"F363","DOI":"10.1152\/ajprenal.00217.2004","article-title":"Phosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation","volume":"288","author":"Baum","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2019041122104117700_B49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"issue":"5","key":"2019041122104117700_B50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000107069","article-title":"New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter","volume":"27","author":"Miyamoto","year":"2007","journal-title":"Am J Nephrol"},{"issue":"7","key":"2019041122104117700_B51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"issue":"11","key":"2019041122104117700_B52","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"6","key":"2019041122104117700_B53","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/jbmr.3096","article-title":"VDR in osteoblast-lineage cells primarily mediates vitamin D treatment-induced increase in bone mass by suppressing bone resorption","volume":"32","author":"Nakamichi","year":"2017","journal-title":"J Bone Miner Res"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/7\/2741\/25096088\/en.2018-00109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T15:25:56Z","timestamp":1555082756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/7\/2741\/5032634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,5]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00109","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,6,5]]}}}